Rakova et al. described that higher TIM-3 expression is associated with functionally licensed NK cell phenotype and better survival in AML patients [41], further supporting that the lower expression of TIM-3 found in our AML cohort can be correlated with a phenotype of dysfunctional immune cells. Here, HAVCR2 is linked to acute myeloid leukemia.